LPL Financial
AERI

LPL Financial’s Aerie Pharmaceuticals AERI Stock Holding History

LPL Financial’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,634
Closed -$304K – 4492
2021
Q3 		$304K Buy
26,634
+1,912
+8% +$27.9K ﹤0.01% 3635
2021
Q2 		$396K Buy
24,722
+1,084
+5% +$18.6K ﹤0.01% 3362
2021
Q1 		$422K Buy
23,638
+10,062
+74% +$174K ﹤0.01% 3172
2020
Q4 		$183K Sell
13,576
-315
-2% -$3.81K ﹤0.01% 3555
2020
Q3 		$163K Buy
13,891
+347
+3% +$4.23K ﹤0.01% 3262
2020
Q2 		$200K Buy
13,544
+1,860
+16% +$27.5K ﹤0.01% 3130
2020
Q1 		$158K Buy
11,684
+52
+0.4% +$987 ﹤0.01% 2883
2019
Q4 		$281K Buy
+11,632
New +$241K ﹤0.01% 2833

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LPL Financial's AERI Position: Q4 2021 in Review

LPL Financial sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 26,634 shares — an estimated $304K sold.

LPL Financial first reported a position in AERI in Q4 2019 and held it in 8 quarters. The position peaked at $422K in Q1 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • LPL Financial reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • LPL Financial sold 26,634 Aerie Pharmaceuticals shares in Q4 2021, an estimated $304K.
  • LPL Financial first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • LPL Financial's Aerie Pharmaceuticals position peaked at $422K in Q1 2021.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on LPL Financial's 13F filing for Q4 2021, filed 14 Feb 2022.